Graphites-Injeel
D 12, D 30, D 200 0.367 ml each.
Graphites-Injeel forte
D 6, D 12, D 30, D 200 0.275 ml each.
Dry, cracked skin, also eczema with yellow crusts, eczema of the auditory meatus, chronic inflammation of the outer eye, chalazions, chronic (especially atonic) constipation, tendency toward adiposis; emollient action on cicatricial tissue (requires fairly long treatment).
Hydrochinon-Injeel
D 12, D 30, D 200 0.367 ml each.
Hydrochinon-Injeel forte
D 8, D 12, D 30, D 200 0.275 ml each.
Physiologically, hydroquinone is formed in the course of oxidative phosphorylation, when it is rapidly reconverted to quinone by cytochrome B.
Disturbances in the utilization of oxygen, e.g. in impregnation phases, such as bronchial asthma and dermatoses, as well as in precancerous conditions.
Bovista-Injeel
D 12, D 30, D 200 0.367 ml each.
Menorrhagia, eczema (particularly on the backs of the hands), stuttering.
Baryum jodatum-Injeel
D 8, D 12, D 30, D 200 0.275 ml each.
Baryum jodatum-Injeel forte
D 4, D 8, D 12, D 30, D 200 0.220 ml each.
Scrofulosis; tendency toward chills; arteriosclerosis.
In case of thyroid disorders, this preparation may not be administered without prior approval from a physician.
Quassia amara-Injeel
D 10, D 30, D 200 0.367 ml each.
Quassia amara-Injeel forte
D 4, D 10, D 30, D 200 0.275 ml each.
Hepatopathy, cholecystopathy, pancreopathy.
Ledum-Injeel
D 12, D 30, D 200 0.367 ml each.
Ledum-Injeel forte
D 4, D 12, D 30, D 200 0.275 ml each.
Acute and chronic articular and muscular rheumatism; pains are drawn from below upward (Kalmia: from above downward); gout; improvement through cold or cold water.
Coxsackie-Virus-A9-Injeel
D 15, D 30, D 200 0.367 ml each.
Coxsackie-Virus-A9-Injeel forte
D 10, D 15, D 30, D 200 0.367 ml each.
Coxsackie-Virus-A9
D 6; D7; D 8 as single potencies.
Norandrostenolon-phenylpropion-Injeel
D 10, D 30, D 200 0.367 ml each.
In the case of 19-norandrostenolone phenylpropionate (nandrolone phenyl propionate), this is a substance which has been replaced meanwhile by nandrolone decanoate. All anabolics, however, always also possess certain androgenic properties, so that it must be expected that its use will lead to signs of virility in women patients (including an irreversible change in the voice) and premature signs of puberty in boys.
Further side effects are the inhibition of spermatogenesis, accelerated maturation of the bones and cholestasis (the latter only after oral administration).
Contraindications for all anabolics are prostatic adenoma and pregnancy.
The symptoms and clinical pictures indicated above, whereby it should be noted that anabolics not only lead to hypertrophy of the skeletal musculature but also to myocardial hypertrophy.
Methylglyoxal-Injeel
D 12, D 30, D 200 0.367 ml each.
Methylglyoxal is formed in metabolic processes, in small quantities. It is an aldehyde with an additional carbonyl group and is, therefore, excellently suited for hydrogen transfers and for burning off the toxic amino groups from azomethine compounds.
Cellular phases, especially degeneration and neoplasm phases. Special directions regarding dosage see under Glyoxal-Injeel and forte.
Appendicitis-Nosode-Injeel
D 10, D 30, D 200 0.367 ml each.
Appendicitis-Nosode-Injeel forte
D 6, D 10, D 30, D 200 0.275 ml each.
Chronic swelling of the lymph glands, appendicitis and conditions of irritation; experimentally in chronic constipation.
